Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs (CBT)
|ClinicalTrials.gov Identifier: NCT01357577|
Recruitment Status : Active, not recruiting
First Posted : May 20, 2011
Last Update Posted : February 16, 2018
With this research, the investigators hope to learn if cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) works in people who have both PTSD and problems with drugs or alcohol. In the past, people who had problems with drugs and alcohol were not given treatment for their PTSD. It was believed that PTSD treatment would get in the way of their drug and alcohol treatment. Now the investigators believe that the PTSD symptoms may make it harder to avoid using drugs and alcohol, so the investigators want to see if people can get treatment for both problems at the same time.
One hundred-sixty Veterans from 3 sites who have both PTSD and substance use disorders will be in the study. In order to know if the PTSD treatment is helpful, half of the Veterans in this study will receive PTSD treatment and half will continue to get their usual mental health and/or substance abuse treatment. Who gets which treatment will be decided by a random process. The investigators will then compare the 2 groups to see if there are differences in their PTSD symptoms.
|Condition or disease||Intervention/treatment|
|PTSD Substance Use Disorders||Behavioral: Cognitive behavioral therapy for PTSD|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||129 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||CBT for PTSD in Veterans With Co-Occurring Substance Use Disorders|
|Actual Study Start Date :||January 1, 2013|
|Primary Completion Date :||October 31, 2017|
|Estimated Study Completion Date :||April 30, 2018|
Experimental: Arm 1: TAU + CBT
The experimental group will receive treatment as usual (TAU) plus cognitive behavioral therapy (CBT).
Behavioral: Cognitive behavioral therapy for PTSD
The CBT for PTSD model is based on modern theories of posttraumatic reactions that place a premium on the importance of individuals' appraisals of traumatic events, their own reactions and those of others, and the meaning of the experience in terms of oneself and one's place in the world. In addition, the model employs cognitive restructuring to teach individuals how to examine and challenge their trauma-related appraisals.
No Intervention: Arm 2: TAU
The "no intervention" group will receive treatment as usual (TAU).
- PTSD symptom severity [ Time Frame: Conclusion of treatment and 6 months follow-up ]PTSD symptom severity will be measured by the Clinician Administered PTSD Scale (CAPS).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01357577
|United States, Florida|
|James A. Haley Veterans' Hospital, Tampa, FL|
|Tampa, Florida, United States, 33612|
|United States, New York|
|Syracuse VA Medical Center, Syracuse, NY|
|Syracuse, New York, United States, 13210|
|United States, Vermont|
|White River Junction VA Medical Center, White River Junction, VT|
|White River Junction, Vermont, United States, 05009-0001|
|Principal Investigator:||Jessica L Hamblen, PhD||White River Junction VA Medical Center, White River Junction, VT|